Analyst Price Target is $9.00
▲ +350.00% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Chembio Diagnostics in the last 3 months. The average price target is $9.00, with a high forecast of $10.00 and a low forecast of $8.00. The average price target represents a 350.00% upside from the last price of $2.00.
Current Consensus is
The current consensus among 2 investment analysts is to buy stock in Chembio Diagnostics. This rating has held steady since May 2021, when it changed from a Hold consensus rating.
Chembio Diagnostics, Inc. engages in the developing, manufacturing, marketing, and licensing rapid medical tests. It offers rapid point-of-care tests for infectious, tropical and fever, and respiratory diseases; handheld analyzers; and veterinary products. The firm distributes its products to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. The company was founded in 1985 and is headquartered in Hauppauge, NY.